DERMOSCOPY_UK_LTD - Accounts


Company Registration No. 05213637 (England and Wales)
DERMOSCOPY UK LTD
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2018
PAGES FOR FILING WITH REGISTRAR
DERMOSCOPY UK LTD
COMPANY INFORMATION
Directors
Mr Jonathan Bowling
Mrs Annabel Bowling
Company number
05213637
Registered office
Claremont House
1 Market Square
Bicester
Oxon
OX26 6AA
Accountants
Whitley Stimpson Limited
Claremont House
1 Market Square
Bicester
Oxon
OX26 6AA
Business address
6 Hids Copse Road
Cumnor
Oxford
OX2 9JJ
DERMOSCOPY UK LTD
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 MARCH 2018
- 1 -

The directors present their annual report and financial statements for the Period ended 31 March 2018.

Principal activities

During the period, the principal activity of the company continued to be that of medical education and dermatology.

Directors

The directors who held office during the Period and up to the date of signature of the financial statements were as follows:

Mr Jonathan Bowling
Mrs Annabel Bowling

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mr Jonathan Bowling
Director
30 May 2018
DERMOSCOPY UK LTD
BALANCE SHEET
AS AT
31 MARCH 2018
31 March 2018
- 2 -
2018
2017
Notes
£
£
£
£
Fixed assets
Tangible assets
3
11,517
19,672
Current assets
Debtors
4
44,258
42,916
Cash at bank and in hand
249,160
227,840
293,418
270,756
Creditors: amounts falling due within one year
5
(95,414)
(170,846)
Net current assets
198,004
99,910
Total assets less current liabilities
209,521
119,582
Provisions for liabilities
(353)
(2,003)
Net assets
209,168
117,579
Capital and reserves
Called up share capital
6
100
100
Profit and loss reserves
209,068
117,479
Total equity
209,168
117,579

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial Period ended 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the Period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

DERMOSCOPY UK LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2018
31 March 2018
- 3 -
The financial statements were approved by the board of directors and authorised for issue on 30 May 2018 and are signed on its behalf by:
Mr Jonathan Bowling
Mrs Annabel Bowling
Director
Director
Company Registration No. 05213637
DERMOSCOPY UK LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2018
- 4 -
1
Accounting policies
Company information

Dermoscopy UK Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Claremont House, 1 Market Square, Bicester, Oxon, OX26 6AA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

1.2
Reporting period

The company accounts period has been shortened to 31 March 2017 from 31 August 2017. This is to bring the accounting period in line with the tax year. Therefore the comparative amounts in the financial statements (including the related notes) are not entirely comparable.

1.3
Turnover

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% Straight Line
Fixtures, fittings & equipment
25% Straight Line
Computer equipment
25% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

DERMOSCOPY UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 5 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

DERMOSCOPY UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2018
- 6 -
2
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2017 and 31 March 2018
200,000
Amortisation and impairment
At 1 April 2017 and 31 March 2018
200,000
Carrying amount
At 31 March 2018
-
At 31 March 2017
-
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2017
40,481
Additions
299
At 31 March 2018
40,780
Depreciation and impairment
At 1 April 2017
20,809
Depreciation charged in the Period
8,454
At 31 March 2018
29,263
Carrying amount
At 31 March 2018
11,517
At 31 March 2017
19,672
4
Debtors
2018
2017
Amounts falling due within one year:
£
£
Trade debtors
43,055
40,000
Other debtors
1,203
2,916
44,258
42,916
DERMOSCOPY UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2018
- 7 -
5
Creditors: amounts falling due within one year
2018
2017
£
£
Trade creditors
2,000
1,548
Corporation tax
82,968
159,497
Other taxation and social security
171
-
Other creditors
10,275
9,801
95,414
170,846
6
Called up share capital
2018
2017
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary of £1 each
100
100
100
100
2018-03-312017-04-01falseCCH SoftwareCCH Accounts Production 2018.310No description of principal activity30 May 2018Mr Jonathan BowlingMrs Annabel Bowling052136372017-04-012018-03-3105213637bus:Director12017-04-012018-03-3105213637bus:Director22017-04-012018-03-3105213637bus:RegisteredOffice2017-04-012018-03-31052136372018-03-31052136372017-03-3105213637core:OtherPropertyPlantEquipment2018-03-3105213637core:OtherPropertyPlantEquipment2017-03-3105213637core:CurrentFinancialInstruments2018-03-3105213637core:CurrentFinancialInstruments2017-03-3105213637core:ShareCapital2018-03-3105213637core:ShareCapital2017-03-3105213637core:RetainedEarningsAccumulatedLosses2018-03-3105213637core:RetainedEarningsAccumulatedLosses2017-03-3105213637core:ShareCapitalOrdinaryShares2018-03-3105213637core:ShareCapitalOrdinaryShares2017-03-3105213637core:PlantMachinery2017-04-012018-03-3105213637core:FurnitureFittings2017-04-012018-03-3105213637core:ComputerEquipment2017-04-012018-03-3105213637core:NetGoodwill2017-03-3105213637core:OtherPropertyPlantEquipment2017-03-3105213637core:OtherPropertyPlantEquipment2017-04-012018-03-3105213637bus:OrdinaryShareClass12017-04-012018-03-3105213637bus:OrdinaryShareClass12018-03-3105213637bus:PrivateLimitedCompanyLtd2017-04-012018-03-3105213637bus:FRS1022017-04-012018-03-3105213637bus:AuditExemptWithAccountantsReport2017-04-012018-03-3105213637bus:SmallCompaniesRegimeForAccounts2017-04-012018-03-3105213637bus:FullAccounts2017-04-012018-03-31xbrli:purexbrli:sharesiso4217:GBP